Iron deficiency and anemia in heart failure.

@article{avuolu2017IronDA,
  title={Iron deficiency and anemia in heart failure.},
  author={Y{\"u}ksel Çavuşoğlu and Hakan Altay and Mustafa Çetiner and Tolga Sinan G{\"u}venç and Ahmet Temizhan and Dilek Ural and Dogan Yesilbursa and Neslig{\"u}l Yıldırım and Mehmet Birhan Yılmaz},
  journal={Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir},
  year={2017},
  volume={45 Suppl 2},
  pages={
          1-38
        }
}
Heart failure is an important community health problem. Prevalence and incidence of heart failure have continued to rise over the years. Despite recent advances in heart failure therapy, prognosis is still poor, rehospitalization rate is very high, and quality of life is worse. Co-morbidities in heart failure have negative impact on clinical course of the disease, further impair prognosis, and add difficulties to treatment of clinical picture. Therefore, successful management of co-morbidities… CONTINUE READING

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 140 REFERENCES

Turkish registry for diagnosis and treatment of acute heart failure: TAKTIK study.

  • Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir
  • 2016
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

P Ponikowski, DJ van Veldhuisen, +3 authors V Mareev
  • Eur Heart J 2015;36:657–68
  • 2015
VIEW 30 EXCERPTS
HIGHLY INFLUENTIAL

The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study

P Ponikowski, G Filippatos, +3 authors T Lüscher
  • Eur J Heart Fail 2015;17:329–39
  • 2015
VIEW 21 EXCERPTS
HIGHLY INFLUENTIAL

Ferric carboxymaltose in patients with heart failure and iron deficiency.

  • The New England journal of medicine
  • 2009
VIEW 27 EXCERPTS
HIGHLY INFLUENTIAL